Further analysis (Figure 1C) revealed robust EC marker expression in both the MM patients and the HDs and the absence of hematopoietic markers like PTPRC (the gene encoding CD45), ensuring that the analysis was not confounded by the presence of hematopoietic cells expressing endothelial markers [10]. This evidence concerns the gene PTPRC and Miyoshi myopathy.